Pharmaceutical News

Seattle Post Intelligencer - Four of the world’s top 10 animal health companies are either based in the area or use Kansas City as their U.S. headquarters, including Bayer, Boehringer Ingelheim Vetmedica, Fort Dodge Animal Health and Intervet Inc. IVX Animal Health, the world’s

Drug company reps sue for overtime
Providence Journal - Other companies affected are Boehringer Ingelheim Pharmaceuticals Inc., AstraZeneca PLC, Pfizer Inc., Johnson & Johnson, Amgen Inc., Hoffmann-La Roche Inc., GlaxoSmithKline PLC and Bayer AG. Some of the companies deny the allegations, while others are

Florida expects smallest orange crop in 16 years
St. Paul Pioneer Press - immigrants at eight plants in Tennessee, Alabama, Indiana, Missouri, Texas and Virginia. Drug makers Johnson & Johnson and Pfizer Inc. have agreed to sell the U.S. marketing rights to the nonprescription heartburn drug Zantac to Boehringer Ingelheim

CYA Technologies Announces Discrete Object-Level Recovery for IBM
Consumer Electronics Net - CYA customers include global enterprises such as DuPont, SwissRe, Boehringer-Ingelheim, Gruenthal, British Petroleum and the US Army, as well as organizations in multiple industries such as financial services, life sciences, aerospace, government

AIDS 2006 Day Four
ActionAid - South Africa is constitutionally obliged to provide free medicines for poor people and for others at accessible and affordable costs, yet drugs firms like Boehringer Ingelheim and GlaxoSmithKline are charging excessive prices which are killing people

HIV & AIDS Treatment In Practice
Aidsmap - Other supporters include GlaxoSmithKline’s Positive Action Programme (a founding sponsor), the Access 4 Trust, Abbott, Boehringer Ingelheim, Cavidi, the Diana, Princess of Wales Memorial Fund, the Elton John AIDS Foundation, Merck, Roche and Tibotec

BusinessWeek - German drugmaker Boehringer Ingelheim didn’t set out to create a Viagra-like drug for women. The company was simply trying to develop a fast-acting antidepressant, one that patients would respond to in a matter of days, not weeks like most current

A Nation of Guinea Pigs
Wired - Kalantri began worrying about such matters not long after he started recruiting patients for Boehringer Ingelheim. The previous year, he had overseen a trial for Reviparin, an anticlotting drug that improves the health of one out of 65 cardiac

BackWeb s Ordinary Shares Commence Trading on the OTC Bulletin Board
dBusinessNews.com - BackWeb customers include market leaders such as Boehringer Ingelheim, Eastman Kodak, GE Healthcare, Hewlett-Packard, Johnson & Johnson, KLA Tencor, Lam Research, and Pfizer. BackWeb also serves customers through partnerships with BEA, Oracle

The Bill & Melinda Gates Foundation, Merck & Co., Inc., and The
Social Funds - Boehringer-Ingelheim and Unilever to Join Partnership “Merck believes that targeted and comprehensive interventions will lead to long-term healthcare solutions to the challenge of the HIV/AIDS epidemic in developing countries,” said Raymond V

Target screening: Efficient identification and validation of disease
LabTechnologist.com - We have long-standing, successful collaborations with companies such as GlaxoSmithKline, Wyeth, and Boehringer Ingelheim and have more recently entered into discovery partnerships with patient disease foundations including the High Q Foundation (in

Authors and Disclosures
Medscape News - AstraZeneca Pharmaceuticals LP, Proctor and Gamble, sanofi-aventis, Alexion Pharmaceuticals, Inc., Novartis, Boehringer Ingelheim GmbH, Genentech, Inc., Berlex, Inc.; Honoraria: AstraZeneca Pharmaceuticals LP, sanofi-aventis, Boehringer Ingelheim GmbH

BusinessWeek - German drugmaker Boehringer Ingelheim didn’t set out to create a Viagra-like drug for women. The company was simply trying to develop a fast-acting antidepressant, one that patients would respond to in a matter of days, not weeks like most current

HIV & AIDS Treatment In Practice
Aidsmap - Other supporters include GlaxoSmithKline’s Positive Action Programme (a founding sponsor), the Access 4 Trust, Abbott, Boehringer Ingelheim, Cavidi, the Diana, Princess of Wales Memorial Fund, the Elton John AIDS Foundation, Merck, Roche and Tibotec

AIDS 2006 Day Four
ActionAid - South Africa is constitutionally obliged to provide free medicines for poor people and for others at accessible and affordable costs, yet drugs firms like Boehringer Ingelheim and GlaxoSmithKline are charging excessive prices which are killing people

Authors and Disclosures
Medscape News - AstraZeneca Pharmaceuticals LP, Proctor and Gamble, sanofi-aventis, Alexion Pharmaceuticals, Inc., Novartis, Boehringer Ingelheim GmbH, Genentech, Inc., Berlex, Inc.; Honoraria: AstraZeneca Pharmaceuticals LP, sanofi-aventis, Boehringer Ingelheim GmbH

BackWeb s Ordinary Shares Commence Trading on the OTC Bulletin Board
dBusinessNews.com - BackWeb customers include market leaders such as Boehringer Ingelheim, Eastman Kodak, GE Healthcare, Hewlett-Packard, Johnson & Johnson, KLA Tencor, Lam Research, and Pfizer. BackWeb also serves customers through partnerships with BEA, Oracle

Brand-Name Drug Prices Still Rise Faster Than Inflation
MedicineNet.com - Boehringer Ingelheim’s Combivent, a bronchodilator aerosol (12 percent); Pfizer’s Atrovent Inhaler (12 percent); Adventis’ Ambien 10 mg. (9.9 percent); and GlaxoSmithKline’s Wellbutrin, an antidepressant, 150 mg. (9.4 percent), according to the report

Industry Wrapups
San Jose Business Journal - reports 20 percent profit increase [Tuesday] Yahoo’s net income drops 22 percent [Tuesday] Calpine to write off $7.1B in assets [Tuesday] $30B-$35B bond vote coming in fall, California legislators say [Tuesday] Ingenuity inks deal with Boehringer Ingelheim

MSNBC - of drugs that do not contain nevirapine or nevirapine-related drugs. Implementing this policy can improve the health of women who need AIDS treatment. Nevirapine is sold under the brand name Viramune by privately held Boehringer Ingelheim.

A Little Blue Pill For Women?
BusinessWeek - German drugmaker Boehringer Ingelheim didn’t set out to create a Viagra-like drug for women. The company was simply trying to develop a fast-acting antidepressant, one that patients would respond to in a matter of days, not weeks like most current

Overall scope and dimension of the surveys
BioMed Central - DP has received honoraria for speaking at sponsored meetings from the following companies marketing respiratory products: 3 M, Altana, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, IVAX, Merck Sharp & Dohme, Novartis, Pfizer and Schering-Plough

Boehringer Ingelheim and IdeaSphere Announce Acquisition Deal
CattleNetwork.com - INGELHEIM, Germany, NEW YORK and LUGANO, Switzerland, Aug. 25 /PRNewswire/ — Boehringer Ingelheim, the Germany-based pharmaceutical company, and IdeaSphere Inc., the New York-based healthcare company, specializing in vitamins, minerals, nutrition

Female-Arousal Market Heats Up
Advertising Age - Rival German drug maker Boehringer Ingelheim hopes to apply for FDA approval by 2009 for Flibanserin, a Viagra-like pill for women. However, Zestra Laboratories CEO Younis Zubchevich believes none of the pharma solutions will get approval for at

New York Times - Take for instance a spot by Grey Worldwide, part of the WPP Group , for Flomax, a drug sold by Boehringer Ingelheim to help men treat enlarged prostates. Here s to men, the announcer intoned, to guys who want to spend more time having fun

The Bill & Melinda Gates Foundation, Merck & Co., Inc., and The
Social Funds - Boehringer-Ingelheim and Unilever to Join Partnership “Merck believes that targeted and comprehensive interventions will lead to long-term healthcare solutions to the challenge of the HIV/AIDS epidemic in developing countries,” said Raymond V

Deaths, side effects prompt new methadone warning
CNN - A spokesman for Boehringer Ingelheim Pharmaceuticals Inc., whose Roxane Laboratories subsidiary makes Dolophine, did not immediately return a call seeking comment. Methadone is similar to morphine and is most widely used to treat severe pain. The drug

US and European markets looking good
AME Info - In other news, Boehringer Ingelheim Pharmaceuticals announced that it has entered into an agreement with JNJ and Pfizer to acquire the US rights to the over-the-counter Zantac product line for $509.5mln in cash. Novartis (CHF 72.6 ; -0.41% ; NOVN

Salmeterol/Fluticasone Reduces COPD Exacerbations Better Than
Medscape News - Boehringer Ingelheim; Cefalon; Pfizer; Bayer; Merck Darmstadt; Sanofi-Aventis; Talecris; and/or Intermune. In an accompanying editorial, Dennis E. Niewoehner, MD, and Timothy J. Wilt, MD, MPH, of the Veterans Affairs Medical Center and University of

Boehringer Ingelheim and IdeaSphere Announce Acquisition Deal
CattleNetwork.com - INGELHEIM, Germany, NEW YORK and LUGANO, Switzerland, Aug. 25 /PRNewswire/ — Boehringer Ingelheim, the Germany-based pharmaceutical company, and IdeaSphere Inc., the New York-based healthcare company, specializing in vitamins, minerals, nutrition

Consumer Electronics Net - CYA customers include global enterprises such as DuPont, SwissRe, Boehringer-Ingelheim, Gruenthal, British Petroleum and the US Army, as well as organizations in multiple industries such as financial services, life sciences, aerospace, government

Brand-Name Drug Prices Still Rise Faster Than Inflation
MedicineNet.com - Boehringer Ingelheim’s Combivent, a bronchodilator aerosol (12 percent); Pfizer’s Atrovent Inhaler (12 percent); Adventis’ Ambien 10 mg. (9.9 percent); and GlaxoSmithKline’s Wellbutrin, an antidepressant, 150 mg. (9.4 percent), according to the report

ICCR Benchmarks Pharma Responses to AIDS and Diseases of Poverty in
Social Funds - Of the companies operating in all 12 subcategories, US-based Abbott Laboratories ( ABT ) and Germany-based Boehringer Ingelheim scored the worst–28 points for a 2.3 average. “Abbott’s lack of collaboration with generic pharmaceutical companies or

Ten reasons why HPV vaccine is ‘murky’ issue
Evening Star - I also see WIG’s sponsors include 3M Pharmaceuticals, Abbott, Amylin Pharamaceuticals, AstraZeneca Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly. GlaxoSmithKline, Hoffmann-LaRoche, Johnson & Johnson, Merck

Investigational Drugs and Clinical Significance of Antiretroviral Drug
Medscape News - Boehringer Ingelheim Pharmaceuticals, Inc. Kohlbrenner VM, Hall DB, Baxter JD, et al. Limited cross-resistance to tipranavir in patients previously treated with two or more protease inhibitors. Program and abstracts of the 8th International Congress

PRWeb - You do not need any permission to link to any of the pages on this site. Limited copyright is granted for you to use and/or republish any of the press releases on this site for any legitimate media purpose as long as you reference PRWeb as the source

European Respiratory Society 16th Annual Congress
Medscape News - James Donohue, MD, has disclosed that he has received grants for clinical research and educational activities from, and has served as an advisor to, GlaxoSmithKline, Boehringer Ingelheim, Pfizer, ALTANA, AstraZeneca, Novartis, Almirral, Dey, and

ICCR Benchmarks Pharma Responses to AIDS and Diseases of Poverty in
Social Funds - Of the companies operating in all 12 subcategories, US-based Abbott Laboratories ( ABT ) and Germany-based Boehringer Ingelheim scored the worst–28 points for a 2.3 average. “Abbott’s lack of collaboration with generic pharmaceutical companies or

Female-Arousal Market Heats Up
Advertising Age - Rival German drug maker Boehringer Ingelheim hopes to apply for FDA approval by 2009 for Flibanserin, a Viagra-like pill for women. However, Zestra Laboratories CEO Younis Zubchevich believes none of the pharma solutions will get approval for at

Super Bowl Ads of Cartoonish Violence, Perhaps Reflecting Toll of War
New York Times - Take for instance a spot by Grey Worldwide, part of the WPP Group , for Flomax, a drug sold by Boehringer Ingelheim to help men treat enlarged prostates. Here s to men, the announcer intoned, to guys who want to spend more time having fun

US and European markets looking good
AME Info - In other news, Boehringer Ingelheim Pharmaceuticals announced that it has entered into an agreement with JNJ and Pfizer to acquire the US rights to the over-the-counter Zantac product line for $509.5mln in cash. Novartis (CHF 72.6 ; -0.41% ; NOVN

PRWeb - The recognized leader in online news and press release distribution service for small and medium-sized businesses and corporate communications. PRWeb pioneered Free Press Release Distribution and continues to set the standard for online news

BackWeb s Ordinary Shares Commence Trading on the OTC Bulletin Board
dBusinessNews.com - BackWeb customers include market leaders such as Boehringer Ingelheim, Eastman Kodak, GE Healthcare, Hewlett-Packard, Johnson & Johnson, KLA Tencor, Lam Research, and Pfizer. BackWeb also serves customers through partnerships with BEA, Oracle

Kansas City is hub of animal health care
Seattle Post Intelligencer - Four of the world’s top 10 animal health companies are either based in the area or use Kansas City as their U.S. headquarters, including Bayer, Boehringer Ingelheim Vetmedica, Fort Dodge Animal Health and Intervet Inc. IVX Animal Health, the world’s

Salmeterol/Fluticasone Reduces COPD Exacerbations Better Than
Medscape News - Boehringer Ingelheim; Cefalon; Pfizer; Bayer; Merck Darmstadt; Sanofi-Aventis; Talecris; and/or Intermune. In an accompanying editorial, Dennis E. Niewoehner, MD, and Timothy J. Wilt, MD, MPH, of the Veterans Affairs Medical Center and University of

Investigational Drugs and Clinical Significance of Antiretroviral Drug
Medscape News - Boehringer Ingelheim Pharmaceuticals, Inc. Kohlbrenner VM, Hall DB, Baxter JD, et al. Limited cross-resistance to tipranavir in patients previously treated with two or more protease inhibitors. Program and abstracts of the 8th International Congress

BioMed Central - DP has received honoraria for speaking at sponsored meetings from the following companies marketing respiratory products: 3M, Altana, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, IVAX, Merck Sharp & Dohme, Novartis, Pfizer and Schering-Plough

Florida expects smallest orange crop in 16 years
St. Paul Pioneer Press - immigrants at eight plants in Tennessee, Alabama, Indiana, Missouri, Texas and Virginia. Drug makers Johnson & Johnson and Pfizer Inc. have agreed to sell the U.S. marketing rights to the nonprescription heartburn drug Zantac to Boehringer Ingelheim

Investigational Drugs and Clinical Significance of Antiretroviral Drug
Medscape News - Boehringer Ingelheim Pharmaceuticals, Inc. Kohlbrenner VM, Hall DB, Baxter JD, et al. Limited cross-resistance to tipranavir in patients previously treated with two or more protease inhibitors. Program and abstracts of the 8th International Congress

A Nation of Guinea Pigs
Wired - Kalantri began worrying about such matters not long after he started recruiting patients for Boehringer Ingelheim. The previous year, he had overseen a trial for Reviparin, an anticlotting drug that improves the health of one out of 65 cardiac

Brand-Name Drug Prices Still Rise Faster Than Inflation
MedicineNet.com - Boehringer Ingelheim’s Combivent, a bronchodilator aerosol (12 percent); Pfizer’s Atrovent Inhaler (12 percent); Adventis’ Ambien 10 mg. (9.9 percent); and GlaxoSmithKline’s Wellbutrin, an antidepressant, 150 mg. (9.4 percent), according to the report

Medscape News - and Abbott. Dr. Carr has also disclosed that he has served as an advisor or consultant for Roche, GlaxoSmithKline, and Abbott. Dr. Carr has also disclosed that he has received grants for clinical research from Roche and Boehringer Ingelheim.

Roxane accused of price inflation
Columbus Dispatch - A Columbus pharmaceutical manufacturer illegally inflated prices for several of its drugs in attempts to woo customers, according to a federal lawsuit. Boehringer Ingelheim Roxane Inc. and related entities provided inflated prices to states and to

A Little Blue Pill For Women?
BusinessWeek - German drugmaker Boehringer Ingelheim didn’t set out to create a Viagra-like drug for women. The company was simply trying to develop a fast-acting antidepressant, one that patients would respond to in a matter of days, not weeks like most current

Overall scope and dimension of the surveys
BioMed Central - DP has received honoraria for speaking at sponsored meetings from the following companies marketing respiratory products: 3 M, Altana, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, IVAX, Merck Sharp & Dohme, Novartis, Pfizer and Schering-Plough

Authors and Disclosures
Medscape News - AstraZeneca Pharmaceuticals LP, Proctor and Gamble, sanofi-aventis, Alexion Pharmaceuticals, Inc., Novartis, Boehringer Ingelheim GmbH, Genentech, Inc., Berlex, Inc.; Honoraria: AstraZeneca Pharmaceuticals LP, sanofi-aventis, Boehringer Ingelheim GmbH

Super Bowl ads turn dark Patriotic spots of past years give way to
Santa Rosa Press Democrat - Take for instance a spot for Flomax, a drug sold by Boehringer Ingelheim to help men treat enlarged prostates. “Here’s to men,” the announcer intoned, “to guys who want to spend more time having fun and less time in the men’s room.” It was not